COMMUNIQUÉS West-GlobeNewswire

-
Commure Partners with Bethany Children’s Health Center to Help Reduce Clinician Documentation Burden and Enhance Productivity
25/09/2025 -
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
25/09/2025 -
Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology
25/09/2025 -
RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites
25/09/2025 -
CytoDyn to Present on Leronlimab Induction of PD-L1 and Immune Checkpoint Inhibitor Responses in Metastatic Triple-Negative Breast Cancer at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
25/09/2025 -
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani
25/09/2025 -
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
25/09/2025 -
AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors
25/09/2025 -
Silexion Therapeutics Regains Compliance with Nasdaq Listing Requirements
25/09/2025 -
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
25/09/2025 -
HealthEquity Strengthens Executive Leadership Team with Strategic Appointments to Drive Growth and Innovation
25/09/2025 -
Philips joins Optum Healthcare’s network as a preferred provider in the USA
25/09/2025 -
Safety Shot Partners with Monarq Asset Management to Actively Manage BONK Holdings Treasury
25/09/2025 -
PharmAla Partners with Veridion Group as Exclusive Distributor in New Zealand
25/09/2025 -
PCI Biotech update on future operations
25/09/2025 -
Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy
25/09/2025 -
EmblemHealth Commits $2 Million To Combat Food Insecurity in New York City
25/09/2025 -
Levicept to Present Key New Data from Phase II Trial of LEVI-04, a Novel Neurotrophin-3 Inhibitor, at ACR Convergence 2025
25/09/2025 -
Back-to-School Season Brings Hidden Health Risk: New Portable Device Helps Families Navigate September's "Asthma Peak"
25/09/2025
Pages